Hydrochlorothiazide and risk of melanoma and non-melanoma skin cancer
Query 19-05: Hydrochlorothiazide and risk of melanoma and non-melanoma skin cancer. This research is funded by the Drug Safety and Effectiveness Network (DSEN) and conducted
Active Surveillance & Canadian multi-province Cohorts of Pregnant Women and Children
Query 19-03: Active Surveillance & Canadian multi-province Cohorts of Pregnant Women and Children. This research is funded by the Drug Safety and Effectiveness Network (DSEN)
Predictors of chronic opioid use in non-cancer community-dwelling patients
High consumption rates of prescription opioids in Canada raised the need to understand factors associated with chronic use to counteract opioid-related harms (addiction, misuse, abuse
Comparative effectiveness and safety of biosimilars and legacy drugs
In Canada, and worldwide, there is a need for updated, independent, real-world comparative effectiveness and safety data related to biologic drugs including biosimilar drugs. Our
Low dose fluconazole and adverse pregnancy outcomes
Query 16-09: Low dose fluconazole and adverse pregnancy outcomes. This research was funded by the Drug Safety and Effectiveness Network (DSEN) and conducted by the
Ondansetron and fetal abnormality
Query 16-08: Ondansetron use in pregnancy and risk of fetal abnormality. This research was funded by the Drug Safety and Effectiveness Network (DSEN) and conducted